Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd.

SHSE:600613 株式レポート

時価総額:CN¥2.9b

このページの翻訳は実験的なもので、現在開発中です。お待ちしております!

Shanghai Shenqi Pharmaceutical Investment Management マネジメント

マネジメント 基準チェック /14

現在、CEO に関する十分な情報がありません。

主要情報

Feng Bin

最高経営責任者

n/a

報酬総額

CEO給与比率n/a
CEO在任期間13.1yrs
CEOの所有権n/a
経営陣の平均在職期間データなし
取締役会の平均在任期間データなし

経営陣の近況

Recent updates

Why Shanghai Shenqi Pharmaceutical Investment Management's (SHSE:600613) Earnings Are Better Than They Seem

May 06
Why Shanghai Shenqi Pharmaceutical Investment Management's (SHSE:600613) Earnings Are Better Than They Seem

Investor Optimism Abounds Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. (SHSE:600613) But Growth Is Lacking

Apr 17
Investor Optimism Abounds Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. (SHSE:600613) But Growth Is Lacking

CEO(最高経営責任者

Feng Bin (50 yo)

13.1yrs

在職期間

CN¥451,700

報酬

Mr. Feng Bin is the Managing Director and Director of Shanghai Shenqi Pharmaceutical Investment Management Co.,Ltd. (formerly known as Shanghai Wingsung Investment Management Co., Ltd.) and served as its...